Reversal of Left-Ventricular Hypertrophy in Uremic Patients by Treatment with Daily Hemodialysis (DHD)

Buoncristiani, U; Fagugli, Riccardo Maria; Pinciaroli, M R; Kulurianu, Hirissanti; Ceravolo, G; Bova, Carlo

doi:10.1159/000425466

Cited by 55 publications

(37 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hypotensive episodes, hypertensive crisis, cramps and headaches were 7-10 times less frequent in daily dialysis. These findings are similar to those from previous reports on home daily dialysis [9,10,12,20] and may have contributed to the changes of patient's feelings toward the dialysis treatment.…”

Section: Discussionsupporting

confidence: 91%

“…In this setting, short duration daily hemodialysis have been reported to improve some parameters of quality of life, increase hematocrit and allow easier control of blood pressure [9,10,12]. The present study was prospectively designed to assess the feasibility and potential benefits of a short duration daily hemodialysis program when accomplished in a center.…”

Section: Discussionmentioning

confidence: 99%

“…Disappointments have been accumulated regarding to social rehabilitation, blood pressure control, symptoms along the dialysis sessions, and sexual performance of the patients for instance [1]. In search for better options, alternative schedules have been proposed: short high-flux hemodialysis [2][3][4], high-efficiency hemodialysis [5,6], slow long-duration hemodialysis [7,8], short duration daily hemodialysis [1,9,10], and nocturnal hemodialysis [11]. André/Rembold/Pereira/Lugon In this regard, the short duration daily hemodialysis schedule seems particularly impressive for its efficiency and simplicity.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Prospective Evaluation of an In-Center Daily Hemodialysis Program

André¹,

Rembold²,

Pereira

et al. 2002

Am J Nephrol

View full text Add to dashboard Cite

Short duration daily hemodialysis (DHD) emerges as a well-tolerated alternative to standard hemodialysis (SHD). In this prospective study 5 patients in SHD were recruited to participate in an in-center DHD program. The SHD consisted of 3 sessions of 4 h each per week. Nonproportional mixture machines without an ultrafiltration control device and low flow dialyzers were used. For DHD, dialysis equipment and procedures were kept the same. Dialysis sessions, however, began at 6 p.m. (from Monday to Saturday) and lasted 2 h. Data from the last 6 months on SHD of the same patients were compared with the ones from each semester on DHD. Bone biopsy was performed at start and at the end of the 2-year study period. Hypotensive episodes, hypertensive crisis, cramps and headaches became 7–10 times less frequent in daily dialysis. A significant fractional increase (∼12%) was seen in mean values for hematocrit. Predialysis urea levels as well as predialysis creatinine levels declined significantly. Also lower during the daily dialysis period were the mean values for both phosphorus and Ca×P product. Significant increases were found in serum bicarbonate, albumin and in dry weight. The frequency of mean blood pressure ≧110 mm Hg on arrival for dialysis was significantly lower in every semester on daily hemodialysis. A significant twofold improvement in quality of life scoring was observed. Finally, daily hemodialysis also seemed to be beneficial to low turnover bone disease and bone aluminum deposition. These beneficial effects occurred despite of an increase in the frequency of missing days. Results from the present study which prospectively addressed the role of in-center short daily hemodialysis in the management of ESRD are encouraging.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Prospective Evaluation of an In-Center Daily Hemodialysis Program

André¹,

Rembold²,

Pereira

et al. 2002

Am J Nephrol

View full text Add to dashboard Cite

show abstract

“…First, a lower percentage of hypertensive patients (83%) were able to stop antihypertensive medication and were normotensive at the end of 6 months. Second, they report a significant reduction in left ventricular hypertrophy; a point not reported from Tassin but noted by earlier workers as well (7)(8)(9). Arguably, sodium and/or volume control, as explanatory interventions seem more readily achieved with the 6-7 dialysis treatments per week, especially if administered by a longer duration of treatment.…”

mentioning

confidence: 62%

Therapeutic use of the Dialysis Prescription for Improvement in Blood Pressure Control

Henderson

Owen

2002

Int J Artif Organs

View full text Add to dashboard Cite

“…Daily hemodialysis, which provides better control of extracellular volume than any other dialytic modality, leads to reductions in left ventricular hypertrophy (25). There are strong indications that prevention of extracellular volume expansion will have major beneficial effects on the morbidity and mortality of PD patients.…”

Section: Regulation Of the Extracellular Volume As A Criterion Of Pd mentioning

confidence: 99%

Adequacy of Peritoneal Dialysis after the ADEMEX Study. Back to the Basics

2002

Int J Artif Organs

View full text Add to dashboard Cite

Reversal of Left-Ventricular Hypertrophy in Uremic Patients by Treatment with Daily Hemodialysis (DHD)

Cited by 55 publications

References 0 publications

Prospective Evaluation of an In-Center Daily Hemodialysis Program

Prospective Evaluation of an In-Center Daily Hemodialysis Program

Therapeutic use of the Dialysis Prescription for Improvement in Blood Pressure Control

Adequacy of Peritoneal Dialysis after the ADEMEX Study. Back to the Basics

Contact Info

Product

Resources

About